市场调查报告书
商品编码
1168275
医疗保健的机器人工学市场- 各主题情报Robotics in Healthcare - Thematic Intelligence |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
医疗机构将加大对医疗机器人的投资,以填补人员短缺并提高护理标准。2020年医疗保健机器人市场价值47亿美元。预计未来该市场将以12%的年复合成长率成长,到2030年将达到145亿美元。在骨科和神经外科机器人销量成长的推动下,手术机器人有望引领市场。
本报告提供医疗保健的机器人工学市场相关调查,市场概要,以及市场规模与成长预测,机器人工学对医疗保健的影响等。
Macroeconomic factors will drive healthcare's use of robotics
The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.
Medical robots improve the standard of care
Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.
Double-digit growth is expected in the next decade
Robotics is a fast-growing industry. GlobalData expects every segment of the robotics market to grow over the next decade. According to GlobalData forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.
Industrial robots will enhance smart pharma manufacturing
The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, GlobalData's Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.